A parent's guide to understanding oral probiotic combinations and how multi-strain formulas may support children's ENT and oral microbiome wellness.*
If you've been exploring oral probiotics for your child, you've probably seen two very different types of products on the market. On one side, you have more conventional gut probiotic gummies — the ones packed with Lactobacillus acidophilus and Bifidobacterium strains formulated to support digestive health.* On the other, you have a newer category that focuses on a different area of the body: oral probiotics, formulated to support the microbiome of the mouth, throat, and upper ENT area.*
Within that second category, one strain frequently appears in the scientific literature: BLIS K12™ (Streptococcus salivarius K12). It is among the more extensively researched oral probiotic strains studied for children's upper ENT and oral microbiome support, with over 20 years of safety-related data and numerous published studies behind it.*
But here's something that doesn't get talked about enough: some thoughtfully formulated oral probiotic products don't stop at BLIS K12™ alone. They combine it with specific Lactobacillus strains — Lactobacillus paracasei, Lactobacillus rhamnosus, and Lactobacillus reuteri — that emerging research suggests may provide complementary support to the oral and upper ENT microbiome.*
In this post, I'll walk you through what the science currently tells us about each of these strains, why their combination with BLIS K12™ is of interest to researchers, and what to consider when evaluating a multi-strain oral probiotic formula for your child.
Why BLIS K12™ Is Often Considered a Key Part of Oral Probiotic Support for Children
Before we talk about the supporting cast, it helps to understand why BLIS K12™ is so central to many conversations about oral probiotics for kids.
BLIS K12™ is a strain of Streptococcus salivarius, a bacterium that naturally lives in the mouth and upper throat. Some research has observed higher levels of S. salivarius in children with indicators of good oral and throat wellness, which led scientists to study specific strains of this species in more detail.*
You can think of BLIS K12™ as one model researchers look at when they study what a healthy oral microbiome might look like. Investigators essentially asked: what's different about the microbiome profile in children whose mouths and throats appear to be doing well, compared with those whose oral and throat microbiome patterns look different?*
In clinical and laboratory studies, BLIS K12™ has been shown to colonize the oral cavity and throat tissues and to produce specialized proteins called Bacteriocin-Like Inhibitory Substances — BLIS, for short — which are being studied for their role in supporting a healthy microbial balance in the mouth and upper throat.* BLIS K12™ has been granted GRAS (Generally Recognized as Safe) status for certain uses by the U.S. Food and Drug Administration, and it has been studied in children as young as three years of age.*
Research suggests BLIS K12™ can establish and maintain a presence in the oral environment, supporting a healthy balance of bacteria in the areas it colonizes.* At the same time, many scientists are interested in whether adding other strains with different characteristics might offer additional, complementary benefits to the oral microbiome.*
Meet the Supporting Strains: Lactobacillus paracasei, L. rhamnosus, and L. reuteri
While BLIS K12™ is a leading focus in the oral probiotic space, a growing body of research has begun examining specific Lactobacillus strains for their potential role in supporting the oral and upper ENT microbiome.* Let's look at what the science says about each one so far.
Lactobacillus paracasei
Lactobacillus paracasei is a lactic acid-producing bacterium that has been studied for its ability to support a balanced oral microbial environment in laboratory and experimental settings.* In in vitro (test-tube) studies, L. paracasei has been observed to produce metabolites — including organic acids and hydrogen peroxide — that can influence the growth of certain oral microorganisms and are being explored for their role in maintaining a healthy oral microbial balance.*
One in vitro study found that L. paracasei metabolites, including organic acids and hydrogen peroxide, were associated with a more balanced oral microbial environment by affecting certain oral bacteria in these laboratory models.* Additionally, another in vitro experiment suggested that L. paracasei could help promote conditions that favor beneficial oral bacterial communities, further contributing to a healthy microbial balance in the mouth.*
From a practical standpoint, L. paracasei may help reinforce the overall microbial "landscape" that BLIS K12™ helps establish, potentially offering another layer of support to maintain a healthy oral microbiome balance.* These findings are early-stage and come primarily from laboratory models, but they help build a scientific rationale for including this strain alongside BLIS K12™ in some oral probiotic formulas.*
Lactobacillus rhamnosus
Lactobacillus rhamnosus — and particularly the well-studied GG strain — is one of the most researched probiotic bacteria in the world.* While much of the research on L. rhamnosus GG has focused on gut health, an emerging body of evidence has begun to explore its potential contributions to the oral and upper respiratory microbiome.*
A study published in Frontiers in Microbiology reported that L. rhamnosus and L. reuteri influenced mucosal surface characteristics and were associated with a balanced oral microbial environment in experimental models.* This is noteworthy because the mucosal surfaces of the mouth and throat are important "real estate" where oral bacteria can adhere and form communities.
A more recent preprint study reported that L. rhamnosus was associated with changes in biofilm formation by certain oral bacteria in laboratory testing, suggesting it may influence how microbial communities organize themselves on these surfaces.* Biofilm formation is one way oral bacteria establish themselves on mucosal surfaces — so a strain that appears to affect this process in vitro may help maintain a microbial environment that is more favorable for beneficial bacteria like BLIS K12™ to colonize and persist.* These data are preliminary and come from laboratory research rather than large clinical trials, but they provide interesting mechanistic clues.*
A randomized, double-blind, placebo-controlled clinical trial also found that daily milk supplemented with L. rhamnosus GG was associated with certain upper respiratory health-related outcomes in children during the winter season.* While this was a gut-delivery format rather than an oral lozenge, and the study was not designed specifically to evaluate oral probiotics, the findings add to the broader picture of how this strain might support aspects of children's upper wellness, although the study was not designed to evaluate dietary supplements for the treatment or prevention of respiratory illnesses.*
Lactobacillus reuteri
Lactobacillus reuteri has also developed a meaningful research profile connected to oral health, with studies examining its role in supporting gum health, dental parameters, and, more recently, its potential synergy with other probiotic strains in upper ENT microbiome support.* Much of this work is still emerging and includes both clinical and in vitro research.*
As mentioned above, L. reuteri and L. rhamnosus together were reported to influence mucosal surface integrity and contribute to a balanced oral microbial environment in one study.* A separate study suggested a possible mechanism: L. rhamnosus and L. reuteri together appeared to support oral mucosal cell health and balanced microbial conditions in vitro, potentially through the production of lactic acid and interactions with a component called lipoteichoic acid, which in laboratory models has been linked with effects on mucosal cell integrity.* This kind of multi-step, mechanistic interaction between strains is exactly the kind of question modern probiotic science is increasingly interested in exploring.
What makes L. reuteri particularly interesting as a companion to BLIS K12™ is that both have been evaluated in contexts related to the oral and upper respiratory environment.* While BLIS K12™ has been studied for its ability to colonize the mouth and upper throat, certain Lactobacillus strains like L. reuteri are being investigated for their influence on mucosal surfaces and microbial ecology in nearby areas.* Together, they may offer complementary mechanisms that support overall oral and ENT microbiome wellness, though more clinical research is needed to fully understand these interactions in children.*
Why Complementary Strains Matter: The Case for Multi-Strain Oral Probiotics
Here's something I want every parent to understand about probiotics: including more strains in a formula doesn't automatically make it better. What matters more is whether the strains you're combining have characteristics and mechanisms that complement one another, rather than simply duplicating each other's roles.
The combination of BLIS K12™ with L. paracasei, L. rhamnosus, and L. reuteri is being explored from a complementary standpoint for several reasons:
- BLIS K12™ has been studied for its ability to colonize the oral cavity and throat and to produce BLIS proteins that help maintain microbial balance through competitive interactions with other microbes.*
- L. rhamnosus and L. reuteri have been examined for their potential role in supporting the integrity of oral mucosal surfaces and helping maintain a balanced oral microbial environment in experimental models.*
- L. paracasei has been studied in vitro for its metabolite-driven support of a healthy oral microbial balance, potentially influencing the same broad categories of microorganisms through a distinct biochemical pathway.*
- Together, these strains are being evaluated for their potential to support the oral microbiome through multiple complementary mechanisms — a concept sometimes described as "multi-modal probiotic support."*
It's also worth noting that, unlike gut probiotics that are swallowed and must survive the highly acidic environment of the stomach to reach the intestines, an oral probiotic delivered as a chewable lozenge or tablet is intended to bring the probiotic bacteria into direct contact with the tissues they are meant to support. This direct-contact delivery method is a key feature of many oral microbiome-targeted supplements and is one reason why the format of delivery matters when you are thinking about supporting the mouth and upper throat.
What This Means for Choosing a Children's Oral Probiotic
As a naturopathic doctor and a parent myself, I approach supplement choices with the same questions I use in clinical practice: Is there research behind this? Are the strains appropriate for the intended purpose? Is the delivery method logical for where support is intended? And can I feel comfortable discussing this option with a parent who trusts me?
When evaluating a children's oral probiotic, here are a few things you may want to consider:
1. BLIS K12™ as a Key Strain
BLIS K12™ is one of the more extensively studied oral probiotic strains for children's oral and upper ENT microbiome support, with a combination of safety and mechanistic data spanning more than two decades.* If you're looking at an oral probiotic for your child, it can be helpful to see whether BLIS K12™ or another strain shown to colonize the mouth and throat is included in the formula.*
Some products marketed for ENT or oral support rely primarily on traditional gut probiotic strains. While those strains can be valuable for digestive wellness, parents may also want to review whether the strains have been studied in the oral and upper ENT environment if that is their primary goal.*
2. Complementary Lactobacillus Strains With Oral/ENT Research
Not all Lactobacillus strains have been evaluated in the oral and upper ENT environment. Look for formulas that specifically include strains such as L. paracasei, L. rhamnosus, and/or L. reuteri that are being studied in relation to oral and upper respiratory microbiome support, rather than relying only on generic gut-focused strains.* Pay attention as well to how the manufacturer summarizes the research and whether they distinguish between early-stage (in vitro) data and human clinical trials.*
3. Chewable Lozenge or Tablet Delivery Format
The delivery format matters a great deal for oral probiotics. A chewable tablet or lozenge that dissolves slowly in the mouth allows the probiotic bacteria to come into close contact with the oral and throat tissues where they are intended to support microbiome balance.* Research on BLIS K12™ has frequently been conducted using this type of delivery, and many study protocols involved taking the lozenge in the evening, often after brushing teeth, to support colonization in the mouth and upper throat.*
4. Thoughtful Sweetener Choices
Because oral probiotics are often taken after brushing teeth at bedtime, the sweeteners in the formula can be an important consideration from a dental wellness perspective. Some parents and dental professionals prefer products that use non-sugar sweeteners such as xylitol, stevia, or isomalt rather than sugar or high-sugar sweeteners.* If you have questions about sweeteners and your child's teeth, it's always a good idea to speak with your child's dentist or pediatrician.*
5. Clearly Labeled CFU Counts for Children
Many of the studies on BLIS K12™ have used daily doses around 1 billion CFU or more.* When you look at products, it can be helpful to check whether they specify the CFU (colony forming unit) count. This type of labeling helps you understand how the product aligns with the dosing used in published research.
A Note on Emerging Research
I want to be transparent about something that I think good science communication requires: the research on L. paracasei, L. rhamnosus, and L. reuteri specifically as oral probiotic strains is newer and less extensive than the research on BLIS K12™.* Much of the data I've described above comes from in vitro (laboratory) studies and early-stage clinical or mechanistic research, rather than large-scale randomized controlled trials specifically examining oral probiotic lozenges in children.*
This doesn't mean the research is unimportant. In vitro mechanistic studies are a critical first step in understanding how organisms interact, and the mechanistic rationale for these strains' potential supportive roles is scientifically compelling.* But it does mean that I present this information as emerging science — promising, grounded in early evidence, and worthy of continued investigation — rather than as definitive clinical proof for all children.*
What I can say with confidence is this: the potential mechanistic interactions between these strains are biologically plausible and scientifically interesting, and these strains have generally favorable safety profiles when used as probiotics in studied populations.* As more research emerges, we'll gain a clearer picture of the most appropriate and effective multi-strain oral probiotic approaches for children.*
The Bottom Line From Dr. Oskin
The oral microbiome is a dynamic, living ecosystem that may play an important role in your child's oral and upper ENT wellness.* Supporting it with targeted probiotic strains — led by the well-researched BLIS K12™ and complemented by Lactobacillus strains that are being actively studied in this area — is one approach some families consider as part of a thoughtful daily wellness routine, in partnership with their child's healthcare provider.*
Not all oral probiotics are formulated the same way. The specific strains, the delivery format, and the quality standards behind the product can all influence how well a formula aligns with the available science and with your family's values and goals. As you evaluate your options, I hope this deep dive into the research landscape has given you a clearer lens through which to make that decision for your family.
As always, I recommend discussing any new supplement with your child's pediatrician or a qualified healthcare provider before getting started. Every child is unique, and the best decisions are always made in partnership with someone who knows your child's full health picture.
Ready to learn more about the oral microbiome and what the science currently suggests about supporting your child's ENT wellness in a natural, research-informed way? Explore more evidence-based education from Dr. Jamie Oskin, ND, at getlittlekoala.com.
The following references include both laboratory and clinical studies and are provided as background on probiotic and oral microbiome research. Some of these papers investigate disease-related endpoints, which are not intended as claims for any dietary supplement product.*
Disclaimers
*These statements have not been evaluated by the U.S. Food and Drug Administration. Any products discussed are not intended to diagnose, treat, cure, or prevent any disease.
Always consult your child's pediatrician or a qualified healthcare provider before starting any new supplement regimen.
About the Author
Dr. Jamie Oskin, ND is a naturopathic doctor with nearly two decades of clinical experience in pediatric wellness and a deep focus on the oral and ENT microbiome. As the founder of Little Koala and the medical voice behind getlittlekoala.com, Dr. Oskin is committed to bringing evidence-based, parent-friendly education to families navigating children's ENT and oral wellness. Learn more at droskin.com.
